112 related articles for article (PubMed ID: 15942709)
1. Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use?
Inamori M; Togawa J; Iwasaki T; Ozawa Y; Kikuchi T; Muramatsu K; Chiguchi G; Matsumoto S; Kawamura H; Abe Y; Kirikoshi H; Kobayashi N; Shimamura T; Kubota K; Sakaguchi T; Saito S; Ueno N; Nakajima A
J Gastroenterol; 2005 May; 40(5):453-8. PubMed ID: 15942709
[TBL] [Abstract][Full Text] [Related]
2. Effect of Helicobacter pylori status on intragastric pH during administration of lafutidine or famotidine.
Koike T; Ohara S; Sehine H; Kawamura M; Abe Y; Inomata Y; Iijima K; Imatani A; Shimosegawa T
Hepatogastroenterology; 2007 Jun; 54(76):1280-4. PubMed ID: 17629089
[TBL] [Abstract][Full Text] [Related]
3. A new-generation H2 receptor antagonist: quicker and stronger acid inhibition than proton pump inhibitors in the clinical setting?
Tsuji S; Kawano S
J Gastroenterol; 2005 May; 40(5):549-50. PubMed ID: 15942726
[No Abstract] [Full Text] [Related]
4. Effect of low-dose rabeprazole and omeprazole on gastric acidity: results of a double blind, randomized, placebo-controlled, three-way crossover study in healthy subjects.
Bruley des Varannes S; Gharib H; Bicheler V; Bost R; Bonaz B; Stanescu L; Delchier JC; Bonnot-Marlier S
Aliment Pharmacol Ther; 2004 Oct; 20(8):899-907. PubMed ID: 15479362
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effect on intragastric pH of a single dose of omeprazole or rabeprazole: which is suitable for on-demand therapy?
Inamori M; Togawa J; Takahashi K; Yoneda M; Fujisawa N; Iwasaki T; Ozawa Y; Kikuchi T; Muramatsu K; Chiguchi G; Matsumoto S; Kawamura H; Abe Y; Kirikoshi H; Kobayashi N; Sakaguchi T; Takamura T; Nakajima A; Ueno N; Sekihara H
J Gastroenterol Hepatol; 2003 Sep; 18(9):1034-8. PubMed ID: 12911659
[TBL] [Abstract][Full Text] [Related]
6. The effect of rabeprazole on regional gastric acidity and the postprandial cardia/gastro-oesophageal junction acid layer in normal subjects: a randomized, double-blind, placebo-controlled study.
Vo L; Simonian HP; Doma S; Fisher RS; Parkman HP
Aliment Pharmacol Ther; 2005 Jun; 21(11):1321-30. PubMed ID: 15932362
[TBL] [Abstract][Full Text] [Related]
7. Effect of esomeprazole and rabeprazole on intragastric pH in healthy Chinese: an open, randomized crossover trial.
Li ZS; Zhan XB; Xu GM; Cheng NN; Liao Z
J Gastroenterol Hepatol; 2007 Jun; 22(6):815-20. PubMed ID: 17565634
[TBL] [Abstract][Full Text] [Related]
8. Early effects of oral administration of lafutidine with peppermint oil, compared with lafutidine alone, on intragastric pH values.
Iida H; Inamori M; Uchiyama T; Endo H; Hosono K; Akiyama T; Sakamoto Y; Fujita K; Takahashi H; Yoneda M; Koide T; Tokoro C; Goto A; Abe Y; Kobayashi N; Kirikoshi H; Kubota K; Saito S; Nakajima A
Hepatogastroenterology; 2011; 58(105):235-8. PubMed ID: 21510321
[TBL] [Abstract][Full Text] [Related]
9. Nocturnal gastric acid breakthrough during the administration of rabeprazole and ranitidine in Helicobacter pylori-negative subjects: effects of different regimens.
Adachi K; Komazawa Y; Fujishiro H; Mihara T; Ono M; Yuki M; Kawamura A; Karim Rumi MA; Amano Y; Kinoshita Y
J Gastroenterol; 2003; 38(9):830-5. PubMed ID: 14564627
[TBL] [Abstract][Full Text] [Related]
10. Lafutidine, a newly developed antiulcer drug, elevates postprandial intragastric pH and increases plasma calcitonin gene-related peptide and somatostatin concentrations in humans: comparisons with famotidine.
Shimatani T; Inoue M; Kuroiwa T; Xu J; Nakamura M; Tazuma S; Ikawa K; Morikawa N
Dig Dis Sci; 2006 Jan; 51(1):114-20. PubMed ID: 16416222
[TBL] [Abstract][Full Text] [Related]
11. Early effects of oral administration of lafutidine with mosapride compared with lafutidine alone on intragastric pH values.
Iida H; Inamori M; Nozaki Y; Endo H; Hosono K; Akiyama T; Sakamoto Y; Takahashi H; Koide T; Tokoro C; Abe Y; Nakajima A
BMC Gastroenterol; 2009 Jul; 9():52. PubMed ID: 19589146
[TBL] [Abstract][Full Text] [Related]
12. A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects.
Williams MP; Sercombe J; Hamilton MI; Pounder RE
Aliment Pharmacol Ther; 1998 Nov; 12(11):1079-89. PubMed ID: 9845397
[TBL] [Abstract][Full Text] [Related]
13. Effects of a single dose of rabeprazole 20 mg and pantoprazole 40 mg on 24-h intragastric acidity and oesophageal acid exposure: a randomized study in gastro-oesophageal reflux disease patients with a history of nocturnal heartburn.
Miner P; Delemos B; Xiang J; Lococo J; Ieni J
Aliment Pharmacol Ther; 2010 May; 31(9):991-1000. PubMed ID: 20132153
[TBL] [Abstract][Full Text] [Related]
14. Rabeprazole produces rapid, potent, and long-acting inhibition of gastric acid secretion in subjects with Helicobacter pylori infection.
Ohning GV; Barbuti RC; Kovacs TO; Sytnik B; Humphries TJ; Walsh JH
Aliment Pharmacol Ther; 2000 Jun; 14(6):701-8. PubMed ID: 10848652
[TBL] [Abstract][Full Text] [Related]
15. Oral rabeprazole vs. intravenous pantoprazole: a comparison of the effect on intragastric pH in healthy subjects.
Armstrong D; James C; Camacho F; Chen Y; Horbay GL; Teixeira B; Husein-Bhabha FA
Aliment Pharmacol Ther; 2007 Jan; 25(2):185-96. PubMed ID: 17116123
[TBL] [Abstract][Full Text] [Related]
16. Comparison of lafutidine and rabeprazole in 7-day second-line amoxicillin- and metronidazole-containing triple therapy for Helicobacter pylori: a pilot study.
Kudo T; Fujinami H; Ando T; Nishikawa J; Ogawa K; Hosokawa A; Orihara T; Murakami J; Takahara T; Sugiyama T
Helicobacter; 2012 Aug; 17(4):277-81. PubMed ID: 22759327
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic properties of lafutidine after postprandial oral administration in healthy subjects: comparison with famotidine.
Ikawa K; Shimatani T; Hayato S; Morikawa N; Tazuma S
Biol Pharm Bull; 2007 May; 30(5):1003-6. PubMed ID: 17473452
[TBL] [Abstract][Full Text] [Related]
18. Effect of omeprazole 10 mg on intragastric pH in three different CYP2C19 genotypes, compared with omeprazole 20 mg and lafutidine 20 mg, a new H2-receptor antagonist.
Shimatani T; Inoue M; Kuroiwa T; Horikawa Y; Mieno H; Nakamura M
Aliment Pharmacol Ther; 2003 Dec; 18(11-12):1149-57. PubMed ID: 14653835
[TBL] [Abstract][Full Text] [Related]
19. Stronger inhibition of gastric acid secretion by lafutidine, a novel H2 receptor antagonist, than by the proton pump inhibitor lansoprazole.
Yamagishi H; Koike T; Ohara S; Horii T; Kikuchi R; Kobayashi S; Abe Y; Iijima K; Imatani A; Suzuki K; Hishinuma T; Goto J; Shimosegawa T
World J Gastroenterol; 2008 Apr; 14(15):2406-10. PubMed ID: 18416470
[TBL] [Abstract][Full Text] [Related]
20. The effects of oral rabeprazole on endocrine and gastric secretory function in healthy volunteers.
Dammann HG; Burkhardt F; Wolf N
Aliment Pharmacol Ther; 1999 Sep; 13(9):1195-203. PubMed ID: 10468701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
